Compliance updated on Jun 19, 2026 Screened by AAOIFI-Certified Shariah Advisor & Auditor

Financial data updated nightly

Organogenesis Holdings Inc

ORGO ✓ COMPLIANT ☆ Track — members

Nasdaq · Healthcare · Biotechnology & Medical Research ·

USA Micro Cap Analyst: HOLD

Last Close

$1.79

▲ +1.70%

Market Cap $230.33M · Vol 145.12K

Key Metrics

P/E Ratio

N/A

FWD: N/A

Market Cap

$230.33M

Micro Cap

Div Yield

N/A

EPS Growth

-700.00%

YoY

RSI (14)

12.75

Momentum

Beta

1.25

vs Market

52W High

$7.06

74.65% below

52W Low

$1.54

16.23% above

Volume

145.12K

Avg 258.21K

P/B

2.19

Price-to-book

ROE

N/A

Return on equity

Free Float

52.37%

Public shares

Shariah Compliance8 STANDARDS

✓ Yes, Organogenesis Holdings Inc (ORGO) stock is Shariah compliant

AAOIFI—
Dow Jones Islamic (DJIM)—
FTSE Shariah—
MSCI Islamic—
S&P Shariah—
Al Rajhi—
Alinma—
Albilad—

Unlock the full Shariah report

See the verdict under each standard, the exact screening ratios, purification and zakat per share. AAOIFI-certified methodology trusted by global Islamic funds.

Which standards does ORGO pass?

The full report shows the verdict under each of the 8 major Shariah standards, with the business-activity and financial-ratio screens behind every one.

Do I need to purify my investment?

Members see the purification amount per share, updated every financial period under the AAOIFI methodology.

Can I calculate zakat for my shares?

Members get zakat per share and a built-in calculator for their exact holding.

Historical Returns

-3.76%

-23.50%

-30.89%

-52.01%

YTD

-65.44%

-61.91%

-33.21%

-88.14%

Financials & Valuation

TTM · Annual

Total Revenue	$564.17M
Net Income	$37.03M
Revenue Growth (YoY)	-56.68%
Gross Margin	75.62%
Operating Margin	11.74%
Net Profit Margin	6.56%
ROE	N/A
ROA · ROIC	8.57% · 8.81%

P/E Ratio	N/A
Forward P/E (FY1)	N/A
PEG Ratio	0.01
P/S	1.20
P/B	2.19
P/FCF	N/A
EPS Growth	-700.00%
Outstanding Shares	128.67M

Technical Indicators

50-Day SMA	$2.37
200-Day SMA	$3.35
RSI (14)	12.75
Beta	1.25
52-Week High	$7.06
52-Week Low	$1.54

Volume Today	145.12K
Avg Daily Volume (30D)	258.21K
Relative Volume	0.56x
Volatility (10D)	125.53
Volatility (30D)	90.61
Free Float	52.37%

Analyst Consensus

HOLD

Current Price $1.79

Mean Target $2.00

52W Low$1.54 52W High$7.06

Current

Target

$1.54 $7.06

Current Analyst target

+11.73% upside potential · 2 analysts

Identifiers

ExchangeNasdaq

FIGIBBG00FGGD311

ISINUS68621F1021

CountryUnited States of America

Sub-IndustryBiotechnology & Medical Research (NEC)

Earnings DateNov 9, 2026

TypeStocks

Instrument TypeORD Ordinary Share

Similar Halal Stocks

LONN.S Lonza Group AG -1.78% RVMD Revolution Medicines Inc +0.85% ONC BeOne Medicines AG -2.40% 068270.KS Celltrion Inc -0.50% ABVX Abivax SA -2.05%

Company Profile

Organogenesis Holdings Inc. is a regenerative medicine company focused on the development, manufacture and commercialization of solutions for the advanced wound care and surgical and sports medicine markets. It offers a portfolio of regenerative products to address patient needs across the continuum of care. Its wound care products include Apligraf for the treatment of venous leg ulcers and diabetic foot ulcers (DFUs); Dermagraft for the treatment of DFUs; PuraPly AM as an antimicrobial barrier, cross-linked with extracellular matrix scaffold for a variety of wound types; and Affinity, Novachor and NuShield placental allografts to address a variety of wound sizes and types as a protective barrier and extracellular matrix scaffold. Its sports medicine products include NuShield as a surgical barrier and PuraForce as a reinforcement matrix in targeted soft tissue repairs; and Affinity, Novachor, PuraPly MZ, PuraPly AM and PuraPly SX for the management of open wounds in a surgical setting.